Addition of rituximab to first-line treatment of Burkitt lymphoma in children and young adults in Tanzania: a cost-utility analysis

MORRELL L., Mawalla W., Tungu M., Jiang J., Chirande L., SCHUH A., Ruhago G., WORDSWORTH S.

Type

Journal article

Publication Date

2026-07-02T00:00:00+00:00

Permalink Close